Go to the list of all blogs
Harry Richardson's Avatar
published in Blogs
Nov 16, 2026
TickeronGET DAILY SIGNALS
Ping An Biomedical (PASW) Drops -68% Over 30 Days After Reverse Split

Ping An Biomedical (PASW) Drops -68% Over 30 Days After Reverse Split

Key Takeaways

  • PASW shares fell roughly 68% over the trailing 30 days, sliding from about $4.72 to $1.53 on a split-adjusted basis.
  • The decline followed a 1-for-40 reverse stock split, a $300 million shelf registration, and a low-near-term-revenue patent acquisition, all set against extremely thin trading liquidity.
  • Ping An Biomedical, formerly Majestic Ideal Holdings, reported sharply lower fiscal 2025 revenue and a net loss, and remains under Nasdaq minimum bid price compliance pressure.
  • A concentrated shareholder base, with one holder controlling roughly 91.56% of voting power, has amplified volatility and liquidity risk in the micro-cap name.
  • The recent $2.3 million patent agreement with Future Biotechnology Group adds an early-stage biomedical option but is not expected to contribute meaningful near-term revenue.
  • Explore PASW's Price Targets, Earnings, and Forecast pages for additional data and analysis.
  • Discover how automated trading strategies track this stock on Trending AI Robots.

Overview of Ping An Biomedical (PASW) and Its Market Position

Ping An Biomedical Co., Ltd. is a Cayman Islands-incorporated holding company that, through its PRC subsidiary New Brand, operates as a one-stop supply chain management (SCM) provider for the apparel industry. Its services span market trend analysis, product design and development, raw material sourcing, production and quality control, and logistics management. The company also manufactures and trades yarns, textiles, and finished garments—with cashmere yarn a key revenue contributor—alongside real estate investment and warehousing activities. It primarily serves brand owners, textile manufacturers, and apparel retailers in China, with additional reach into Hong Kong, Cambodia, and Europe.

The company listed on the Nasdaq Capital Market in July 2025 under the name Majestic Ideal Holdings and adopted the Ping An Biomedical name in September 2025, signaling a stated strategic pivot toward healthcare and biomedical technology alongside its legacy apparel business. As a thinly traded micro-cap with a market capitalization in the low double-digit millions, the stock is highly sensitive to corporate actions and order flow, which investors should weigh carefully. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Recent Stock Performance of PASW: 30 Days and Quarter

Over the last 30 days, PASW fell from roughly $4.72 to $1.53 on a split-adjusted basis, a decline of approximately 68%. The move was marked by extreme volatility: a sharp drop in late October, a brief rebound into the reverse split effective October 23, and then a decisive collapse in early November, when shares tumbled from about $4.40 to below $1.60 over just a couple of sessions on unusually heavy volume.

The trailing-quarter trend has been persistently negative as well. From a split-adjusted level near $5.47 in mid-September, shares have lost roughly 72% through mid-November. This extends a longer slide that began well before the recent consolidation, reflecting both fundamental weakness in the core apparel business and investor concerns about the company's financing and compliance position.

Key Drivers Behind the Recent Decline in PASW Shares

The most significant near-term catalyst was corporate restructuring rather than operating news. A 1-for-40 reverse stock split took effect on October 23, 2026, reducing outstanding shares from roughly 125.1 million to about 3.1 million. Reverse splits are commonly used to restore Nasdaq minimum bid price compliance, and the market frequently treats them as a signal of distress rather than value creation, particularly when combined with other dilutive measures.

On the same day, the company filed a Form F-3 shelf registration covering up to $300 million in securities, raising the prospect of future dilution for existing holders. Separately, the company signed a letter of intent in late October and a definitive purchase agreement on November 4 to acquire three tumor-related medical technology patents from Future Biotechnology Group for $2.3 million—a transaction management framed as a long-term biomedical capacity-building move that is not expected to be a near-term revenue driver. With little new operating news to offset these structural concerns, and given the stock's thin float and wide bid-ask spreads, selling pressure translated into outsized percentage declines.

Factors Influencing Performance Over the Past Quarter

The quarterly decline reflects a broader, multi-month narrative. The company received a Nasdaq minimum bid price deficiency notice in November 2025 and has been working to restore compliance, culminating in the October 2026 reverse split. At an October 29 extraordinary general meeting, shareholders approved an increase in authorized share capital to $12.5 million and a conditional mechanism that could trigger additional automatic reverse splits—ranging from 10-to-1 to 80-to-1—if the share price closes below $1.00 for a sustained period.

Fundamentally, the legacy apparel business has weakened. Fiscal 2025 revenue fell to RMB 34.15 million from RMB 87.62 million the prior year, a decline of roughly 61%, and the company recorded a net loss of about RMB 12.83 million. Concentrated ownership, minimal institutional presence, and limited free float have compounded the stock's downside volatility throughout the period.

Looking Ahead: What Could Shape PASW's Future

Several factors will shape PASW's path ahead. Nasdaq minimum bid price compliance remains a central issue; the conditional future reverse-split provisions mean the stock's ability to hold above $1.00 matters directly. Any drawdown from the $300 million shelf registration would dilute existing shareholders and could pressure the share price further. The completion of the patent acquisition and the proposed strategic investment in Future Biotechnology Group will be watched for execution and any eventual commercialization path, though management has cautioned against expecting near-term revenue. On the operating side, demand for cashmere yarn, input cost trends, and the company's high customer concentration in its apparel supply chain business remain key risks. Given thin liquidity, investors should also monitor trading conditions and spread behavior closely.

Exploring AI-Driven Trading Approaches

In my view, tools like Tickeron’s automated strategies provide a useful layer of perspective when tracking names with thin liquidity and sharp moves. I’ve found the Trending AI Robots page particularly helpful for spotting active bots across different styles and timeframes, allowing a quick comparison of risk profiles without sifting through every option manually. It’s one way I add data-driven context to volatile situations like this.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: PASW

Contributor

Harry Richardson — Algorithmic Trader & Strategy Developer Harry is an algorithmic trader specializing in impulse and breakout trading strategies across cryptocurrency and equity markets. With more than 10 years of experience in developing automated trading systems, he focuses on building structured algorithms designed to capture momentum while maintaining strict risk control. His approach combines quantitative analysis, real-market execution, and continuous performance monitoring. Vitalii prioritizes risk management, drawdown control, and strategy stability over short-term optimization, ensuring algorithms are adaptable to changing market conditions. He has developed and tested hundreds of automated strategies, working extensively with live trading environments, forward testing, and portfolio-level algorithm management. His work centers on transforming trading ideas into fully operational, scalable automated systems.


Momentum Indicator for PASW turns negative, indicating new downward trend

PASW saw its Momentum Indicator move below the 0 level on November 02, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 19 similar instances where the indicator turned negative. In 18 of the 19 cases, the stock moved further down in the following days. The odds of a decline are at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for PASW turned negative on November 03, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 8 similar instances when the indicator turned negative. In 8 of the 8 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.

PASW moved below its 50-day moving average on October 30, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PASW declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

The Aroon Indicator for PASW entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 11 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 11 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +40.99% 3-day Advance, the price is estimated to grow further. Considering data from situations where PASW advanced for three days, in 42 of 50 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.

PASW may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is 7 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 36 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.343) is normal, around the industry mean (1.878). P/E Ratio (-4.666) is within average values for comparable stocks, (31.507). PASW's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (3.950). Dividend Yield (0.000) settles around the average of (0.048) among similar stocks. PASW's P/S Ratio (4.409) is slightly higher than the industry average of (1.630).

The Tickeron Price Growth Rating for this company is 98 (best 1 - 100 worst), indicating slightly worse than average price growth. PASW’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PASW’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 100, placing this stock worse than average.

Industry description

The textiles industry includes companies that spin fiber and weave fabrics into raw products such as polyester filaments and staple yarns that are manufactured into finished products. Albany International Corp., Unifi, Inc. and Culp, Inc. are some of the major players in this business.

Market Cap

The average market capitalization across the Textiles Industry is 453.07M. The market cap for tickers in the group ranges from 3.74K to 11.58B. TRYIY holds the highest valuation in this group at 11.58B. The lowest valued company is UNIR at 3.74K.

High and low price notable news

The average weekly price growth across all stocks in the Textiles Industry was -16%. For the same Industry, the average monthly price growth was -25%, and the average quarterly price growth was -24%. AIN experienced the highest price growth at -9%, while PASW experienced the biggest fall at -26%.

Volume

The average weekly volume growth across all stocks in the Textiles Industry was 75%. For the same stocks of the Industry, the average monthly volume growth was -27% and the average quarterly volume growth was 32%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 62
P/E Growth Rating: 56
Price Growth Rating: 66
SMR Rating: 77
Profit Risk Rating: 100
Seasonality Score: 25 (-100 ... +100)
Trend Prediction Engine 4
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry Textiles

Industry
N/A
Address
Tai Nan West Street
Phone
+852 39152600
Employees
7
Web
https://majestic-holdings-temp.flywheelsites.com
Interact to see
Advertisement
The ADR gapped lower in premarket trading and was at $335.71 in early regular-session trading, -4.65% from Thursday's close of $352.09. The move extends a global AI and chip unwind: investors are cutting crowded semiconductor bets on stretched valuations, rising sector debt, data-center opposition and Nvidia's leadership turmoil, and Nvidia's strong quarter failed to calm sentiment.
Micron shares slid from Thursday's $690.44 close to $635.41, a -7.97% loss, deepening during Friday's regular session after an already soft premarket. The decline was sector-driven, not company-specific: investors kept unwinding AI exposure as Anthropic fell back after its debut, while hawkish Fed comments and doubts about Nvidia's leadership and AI spending returns pressured chip valuations.
Meta Platforms fell from a $596.22 previous close to $583.40, a -2.15% move, with the decline built in premarket trading and held through early Friday action after Thursday's -3.27% drop. The drop was sector-driven, not company-specific: Anthropic slid roughly -6% to -10% premarket on its second trading day, reviving doubts that AI spending will generate returns, and AI-linked megacaps sold off broadly with Nasdaq 100 futures down about -1.5%.
ANT dropped from Thursday's record-debut close of $97.17 to about $88.56 in Friday premarket trading, a -8.86% move ahead of the opening bell, still above its $83 IPO price. The decline came from a broad AI and technology selloff rather than any Anthropic-specific disclosure: Nvidia and AMD traded lower premarket, index futures were sharply down, and renewed doubts over AI spending and valuations drove profit-taking after the +17.07% first-day gain.
IREN dropped -8.33% to $13.21 from Thursday's $14.41 close, with weakness building in premarket and extending through the first hour of regular trading. The decline extends a sector-wide neocloud rout: Anthropic's post-IPO slide and turmoil at Nvidia revived doubts about debt-funded AI data center spending, dragging CoreWeave and Nebius down with it; no IREN-specific news was released.